A 92-year-old man has been started on apixaban to prevent thromboembolism following his knee replacement surgery. | Medibuddy
1st March 2024

A 92-year-old man has been started on apixaban to prevent thromboembolism following his knee replacement surgery.

A 92-year-old man has been started on apixaban to prevent thromboembolism following his knee replacement surgery. The patient has been marked as a level 3 fall risk and is currently delirious.

Select one option which correctly describes an element of the monitoring required when a patient takes apixaban.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.